Ovid Therapeutics (OVID) Stock Insights

OVID price $2.44 +0.18 +8.19%

Ticker
OVID
Price
$2.44
Change
+0.18 +8.19%
Market cap ?
$477.50M
P/E ?
-4.71
Dividend yield ?
0.00%
Beta ?
0.23
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
51
Value
59
Quality
45
Growth
50

Stocklytics score rationale: value 59, quality 45, growth 50.

Financials

2016201720182019202020212022202320242025
00001261722120838277915027483920005660007252000

Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at…

Fair value

OVID fair value $68.80. Price $2.44. Price is 96% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare OVID

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.08—31.09K
2026-08-13-0.08-0.12733.00K21.43K
2026-05-12-0.12-0.12—56.67K
2026-03-180.06-0.10718.00K78.25K
2025-11-12-0.17-0.15132.00K62.60K
2025-08-13-0.06-0.166.27M61.33K
2025-05-13-0.14-0.14130.00K42.50K
2025-03-11-0.13-0.1676.00K100.00K
2024-11-12-0.20-0.19173.00K187.50K
2024-08-130.12-0.22169.00K70.00K
2024-05-14-0.17-0.23148.00K60.00K
2024-03-08-0.22-0.17141.56K60.00K
2023-11-03-0.16-0.18108.97K60.00K
2023-08-04-0.18-0.2175.00K50.00K
2023-05-05-0.19-0.1866.00K20.00K
2023-03-13-0.16-0.1946.28K—
2022-11-08-0.17-0.2111.10K—
2022-08-09-0.21-0.23——
2022-05-10-0.231.171.45M1.31M
2022-03-15-0.38-0.17-416.35M—
2021-11-10-0.17-0.19——
2021-08-16-0.23-0.15——
2021-05-132.531.68208.38M169.87M
2021-03-15-0.34-0.315.70M—
2020-11-12-0.28-0.436.91M8.45M
2020-08-10-0.41-0.38——
2020-05-07-0.37-0.34——
2020-03-11-0.35-0.46——
2019-11-08-0.43-0.37——
2019-08-07-0.34-0.49——
2019-05-07-0.46-0.48——
2019-03-07-0.52-0.55——
2018-11-08-0.53-0.59——
2018-08-09-0.53-0.59——
2018-05-08-0.54-0.48——
2018-03-29-0.45-0.39——
2017-11-09-0.38-0.60——
2017-08-10-0.57-0.39——
2017-06-13-3.48-0.87——
2017-05-05-0.39———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-06Carter Charles RossBuy50.00K——
2026-07-06Carter Charles RossOther0——
2026-07-06Carter Charles RossOther200.00K$1.14228.00K
2026-07-06Carter Charles RossOther206.25K$1.65340.31K
2026-06-15Greka AnnaBuy130.00K$2.26293.80K
2026-06-15Greka AnnaOther0——
2026-04-07PAPADOPOULOS STELIOSBuy17.58K$2.5645.00K
2026-04-07Friedman BartBuy8.79K$2.5622.50K
2026-04-07Fitzgerald Kevin JosephBuy17.58K$2.5645.00K
2026-03-23LEVIN JEREMY MBuy47.33K$1.4066.27K
2026-03-23LEVIN JEREMY MSell47.33K$1.4066.27K
2026-02-26ALEXANDER MARGARET A.Buy1.44M$1.652.37M
2026-02-26PAPADOPOULOS STELIOSBuy65.00K$1.65107.25K
2026-02-26LEVIN JEREMY MBuy957.00K$1.651.58M
2026-02-26Fitzgerald Kevin JosephBuy65.00K$1.65107.25K
2026-02-26Friedman BartBuy65.00K$1.65107.25K
2026-02-26DUNCAN BARBARA GAYLEBuy65.00K$1.65107.25K
2026-02-26Bernstein KarenBuy65.00K$1.65107.25K
2026-02-26Rona Jeffrey ABuy408.75K$1.65674.44K
2026-02-26Rona Jeffrey ABuy68.12K——
2026-02-23ALEXANDER MARGARET A.Sell11.66K$1.4516.90K
2026-02-23Rona Jeffrey ASell8.54K$1.4512.38K
2026-01-04ALEXANDER MARGARET A.Buy890.00K$1.761.57M
2025-12-15LEVIN JEREMY MBuy71.00K——
2025-12-15LEVIN JEREMY MSell71——
2025-12-11LEVIN JEREMY MBuy47.33K$1.4066.27K
2025-12-11LEVIN JEREMY MBuy35.50K$1.4049.70K
2025-12-11LEVIN JEREMY MBuy71——
2025-12-08TAKEDA PHARMACEUTICAL CO LTDBuy1.25M——
2025-12-08TAKEDA PHARMACEUTICAL CO LTDSell1.25K——
2025-03-03PAPADOPOULOS STELIOSBuy90.00K$0.4944.10K
2025-03-01PAPADOPOULOS STELIOSOther0——
2025-02-26ALEXANDER MARGARET A.Sell5.28K$0.562.96K
2025-02-26Rona Jeffrey ASell3.90K$0.562.19K
2025-02-20Fitzgerald Kevin JosephBuy45.00K$0.5725.65K
2025-02-20Friedman BartBuy45.00K$0.5725.65K
2025-02-20Duncan Barbara GayleBuy45.00K$0.5725.65K
2025-02-20Bernstein KarenBuy45.00K$0.5725.65K
2025-02-20LEVIN JEREMY MBuy1.65M$0.57940.50K
2025-02-20Rona Jeffrey ABuy262.50K$0.57149.62K
2025-02-20Rona Jeffrey ABuy43.75K——
2025-02-20ALEXANDER MARGARET A.Buy262.50K$0.57149.62K
2025-02-20ALEXANDER MARGARET A.Buy43.75K——
2025-01-27ALEXANDER MARGARET A.Buy6.81K$0.734.97K
2024-12-12Fitzgerald Kevin JosephBuy90.00K$1.0695.40K
2024-12-12Friedman BartBuy90.00K$1.0695.40K
2024-12-12Duncan Barbara GayleBuy90.00K$1.0695.40K
2024-12-12Bernstein KarenBuy90.00K$1.0695.40K
2024-09-09ALEXANDER MARGARET A.Buy140.00K$1.07149.80K
2024-09-09ALEXANDER MARGARET A.Sell0——
2024-09-09ALEXANDER MARGARET A.Sell175.00K$2.50437.50K
2024-09-09ALEXANDER MARGARET A.Sell315.00K$1.05330.75K
2024-09-09ALEXANDER MARGARET A.Sell100.00K$2.72272.00K
2024-09-09ALEXANDER MARGARET A.Sell70.00K$3.73261.10K
2024-09-09ALEXANDER MARGARET A.Sell2.02K$3.747.56K
2024-09-09ALEXANDER MARGARET A.Sell10.00K$3.2232.20K
2024-09-09ALEXANDER MARGARET A.Sell168.75K$3.68621.00K
2024-07-30Rona Jeffrey ABuy315.00K$1.04329.18K
2024-03-18LEVIN JEREMY MBuy18.25K$2.7650.36K
2024-02-22Tardio JasonBuy168.75K$3.68621.00K
2024-02-22Tardio JasonBuy28.12K——
2024-02-22Rona Jeffrey ABuy28.12K——
2024-02-22Rona Jeffrey ABuy168.75K$3.68621.00K
2024-02-22Poole Robert MichaelBuy30.00K$3.68110.40K
2024-02-22Perone Thomas MichaelBuy168.75K$3.68621.00K
2024-02-22Perone Thomas MichaelBuy28.12K——
2024-02-22LEVIN JEREMY MBuy700.00K$3.682.58M
2024-02-22Friedman BartBuy30.00K$3.68110.40K
2024-02-22Fitzgerald Kevin JosephBuy30.00K$3.68110.40K
2024-02-22Duncan Barbara GayleBuy30.00K$3.68110.40K
2024-02-22Bernstein KarenBuy30.00K$3.68110.40K
2023-12-04LEVIN JEREMY MSell573.27K——
2023-12-04LEVIN JEREMY MSell573.27K——
2023-02-23Tardio JasonBuy175.00K$2.50437.50K
2023-02-23Rona Jeffrey ABuy175.00K$2.50437.50K
2023-02-23Poole Robert MichaelBuy15.00K$2.5037.50K
2023-02-23Perone Thomas MichaelBuy175.00K$2.50437.50K
2023-02-23LEVIN JEREMY MBuy600.00K$2.501.50M
2023-02-23Friedman BartBuy15.00K$2.5037.50K
2023-02-23Fitzgerald Kevin JosephBuy15.00K$2.5037.50K
2023-02-23Duncan Barbara GayleBuy15.00K$2.5037.50K
2023-02-23Bernstein KarenBuy15.00K$2.5037.50K
2022-09-12Tardio JasonSell17.34K$2.1537.29K
2022-07-01TAKEDA PHARMACEUTICAL CO LTDBuy5.75M——
2022-07-01Takeda Pharmaceuticals U.S.A., Inc.Buy1.25K——
2022-07-01Takeda Pharmaceuticals U.S.A., Inc.Buy1.25K——
2022-07-01TAKEDA PHARMACEUTICAL CO LTDBuy1.25K——
2022-07-01TAKEDA PHARMACEUTICAL CO LTDSell1.25K——
2022-07-01TAKEDA PHARMACEUTICAL CO LTDSell5.75M——
2022-04-08Friedman BartBuy69.42K——
2022-04-08Tardio JasonBuy87.50K$3.22281.74K
2022-04-08Tardio JasonBuy10.00K$3.2232.20K
2022-04-08Tardio JasonBuy10.00K——
2022-04-08LEVIN JEREMY MBuy423.24K——
2022-04-08Rona Jeffrey ABuy194.40K$3.22625.96K
2022-04-08Rona Jeffrey ABuy194.40K——
2022-04-08Rona Jeffrey ABuy10.00K$3.2232.20K
2022-04-08Perone Thomas MichaelBuy25.40K$3.2281.78K
2022-04-08Perone Thomas MichaelBuy10.00K$3.2232.20K
2022-04-08Perone Thomas MichaelBuy10.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 135, holders +26 vs prior quarter. Ownership 199.97%.

HolderSharesChangeChange %Value
JUPITER TOPCO LLC20.74M20.74MNew55.90M
EVENTIDE ASSET MANAGEMENT, LLC11.81M1.90M+19.11%31.77M
BLACKROCK, INC.10.82M9.29M+605.90%29.12M
RA CAPITAL MANAGEMENT, L.P.10.50M-213.03K-1.99%28.25M
AFFINITY ASSET ADVISORS, LLC10.14M-491.76K-4.62%27.29M
STATE STREET CORP7.90M7.38M+1418.55%21.25M
VANGUARD CAPITAL MANAGEMENT LLC7.76M2.50M+47.58%20.87M
ADAR1 CAPITAL MANAGEMENT, LLC7.42M2.87M+63.23%19.95M
BALYASNY ASSET MANAGEMENT L.P.6.72M1.19M+21.43%18.07M
ADAGE CAPITAL PARTNERS GP, L.L.C.6.16M00.00%16.58M
FEDERATED HERMES, INC.5.95M2.38M+66.67%16.01M
BRAIDWELL LP5.92M5.92MNew15.92M
GEODE CAPITAL MANAGEMENT, LLC4.07M2.75M+208.98%10.96M
SILVERARC CAPITAL MANAGEMENT, LLC3.10M2.10M+210.11%8.34M
STEMPOINT CAPITAL LP2.42M2.42MNew6.50M
IKARIAN CAPITAL, LLC2.27M-625.00K-21.59%6.11M
POINT72 ASSET MANAGEMENT, L.P.1.95M625.12K+47.34%5.23M
SPHERA FUNDS MANAGEMENT LTD.1.35M-269.83K-16.63%3.64M
NORTHERN TRUST CORP1.25M991.34K+389.06%3.35M
VANGUARD FIDUCIARY TRUST CO1.14M447.50K+64.55%3.07M
PROPEL BIO MANAGEMENT, LLC1.12M194.08K+21.06%3.00M
ROSALIND ADVISORS, INC.1.11M00.00%2.98M
VANGUARD PORTFOLIO MANAGEMENT LLC1.03M1.03MNew2.77M
SIO CAPITAL MANAGEMENT, LLC1.01M-247.05K-19.73%2.70M
ENSIGN PEAK ADVISORS, INC988.08K988.08KNew2.66M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Ovid Therapeutics (OVID) Stock Insights

OVID$2.44+0.18 +8.19%

$477.50M

Market Cap

-4.71

P/E

—

Forward P/E

51

Score

Price History